According to the Zhitong Finance App, Jiuzhou Pharmaceutical (603456.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 3,937 billion yuan, a year-on-year decrease of 5.38%; net profit to mother of 617 million yuan, a year-on-year decrease of 17.50%; deducted non-net profit of 615 million yuan, a year-on-year decrease of 17.54%; and basic earnings per share of 0.69 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.